Lyme disease: prophylaxis after tick bite;Borréliose de Lyme : mesures préventives secondaires après piqûre de tiques

Medecine et Maladies Infectieuses

Volumn 37, Issue 7-8, 2007, Pages 446-455

  Patey, O ^a  

^a Centre Hospitalier Intercommunal de Villeneuve Saint Georges   (France)

Author keywords

Borrelia; Lyme disease; Prophylaxis

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; CEFTRIAXONE; CEFUROXIME; CEFUROXIME AXETIL; CEPHALOSPORIN; DOXYCYCLINE; ERYTHROMYCIN; INSECT REPELLENT; MACROLIDE; PENICILLIN DERIVATIVE; TETRACYCLINE; ANTIINFECTIVE AGENT;

ANTIBIOTIC PROPHYLAXIS; ARTICLE; BORRELIA BURGDORFERI; DISEASE TRANSMISSION; HUMAN; INSECT RESISTANCE; LYME DISEASE; PRIMARY PREVENTION; PROTECTIVE CLOTHING; SPECIES IDENTIFICATION; TICK BITE; TRAVEL; ANIMAL; DRUG EFFECT; FEMALE; INSECT BITE; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; PREGNANCY; PREGNANCY COMPLICATION; REVIEW; RISK FACTOR; TICK;

ANIMALS; ANTI-BACTERIAL AGENTS; BORRELIA BURGDORFERI GROUP; FEMALE; HUMANS; INSECT BITES AND STINGS; LYME DISEASE; MICROBIAL SENSITIVITY TESTS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; RISK FACTORS; TICKS;

EID: 34548382187     PISSN: 0399077X     EISSN: 17696690     Source Type: Journal    
DOI: 10.1016/j.medmal.2006.01.024     Document Type: Article

References (105)

1. Maladie de Lyme. CIM-10 A69.2. In « zoonoses et maladies transmissibles communes à l'homme et aux animaux. OIE Vol. 1 (2005) 142-143
2. Hengge U.R., Tannapfel A., Tyring S.K., Erbel R., Arendt G., and Ruzika T. Lyme borreliosis. Lancet Infect. Dis. 3 (2003) 489-500
3. Parola P., and Raoult D. Ticks and tickborne bacterial diseases in humans: an emerging infectious threat. Clin. Infect. Dis. 32 (2001) 897-928
4. Steere A.C. Borrelia burgdorferi (Lyme Disease, Lyme Borreliosis). In: Mandell G.L., Bennett J.E., and Dolin R. (Eds). Principles and Practice of Infectious Diseases (2005), Churchill Livingstone, New York
5. Shapiro E.D., and Gerber M.A. Lyme disease. Clin. Infect. Dis. 31 (2000) 533-542
6. Staneck G., and Strle F. Lyme borreliosis. Lancet 362 (2003) 1639-1647
7. o spec. (1998) 383-386
8. o spec. (1998) 393-395
9. Evison J., Aebi C., Francioli P., Peter O., Bassetti S., Gervaix A., et al. Borreliose de Lyme. Troisième partie : prévention, grossesse, état d'immunodéficience, syndrome postborreliose de Lyme. Rev. Med. Suisse 2 (2006) 935-940
10. Ploy M.C., and Denis F. Borrelia burgdorferi. In : les bactéries, champignons et parasites transmissibles de la mère à l'enfant (2003), Ed. John Libbey, Médecine Sciences selection 215-231
11. Wormser G.P., Nadelman R.B., Dattwyler R.J., Dennis D.T., Shapiro E.D., Steere A.C., et al. Practice guidelines for the treatment of Lyme disease. Clin. Infect. Dis. 31 Suppl. 1 (2000) S1-S14
12. Kaiser R., and Teilnehmer der expertenkonferenz. Fruhsommermeningoenzephalitis und Lyme borreliose - Prävention vor und nach zeckenstich. Dtsch. Med. Wschr. 123 (1998) 847-853
13. Evison J., Aebi C., Francioli P., Peter O., Bassetti S., Gervaix A., et al. Borreliose de Lyme. Deuxième partie : clinique et traitement. Rev. Med. Suisse 2 (2006) 925-934
14. Murray T., and Feder H. Management of tick bites and early Lyme disease: a survey of Connecticut physicians. Pediatrics 108 (2001) 1367-1370
15. Ziska M.H., Donta S.T., and Demarest F.C. Physician preferences in the diagnosis and treatment of Lyme disease in the United States. Infection 24 (1996) 182-185
16. o spec. (1998) 325-334
17. Van Dam A.P. Diversity of Ixodes-Borne Borrelia species - clinical pathogenetic, and diagnostic implications and impact on vaccine development. Vector Borne Zoonotic Dis. 2 (2002) 249-254
18. Anderson J.F. Epizootiology of Borrelia in Ixodes tick vectors and reservoir hosts. Rev. Infect. Dis. 11 Suppl. 6 (1989) S1451-S1459
19. Fish D. Environmental risk and prevention of Lyme disease. Am. J. Med. 98 Suppl. 4A (1995) (4A2S-4A8S)
20. Jouda F., Perret J.L., and Gern L. Ixodes ricinus density, and distribution and prevalence of Borrelia burgdorferi sensus lato infection along an altitudinal gradient. J. Med. Entom. 41 (2004) 162-169
21. o spec. (1998) 335-343
22. Luft B.J., Gorevic P.D., Halperin J.J., Volkman D.J., and Dattwyler R.J. A perspective on the treatment of Lyme borreliosis. Rev. Infect. Dis. 11 Suppl. 6 (1989) S1518-S1525
23. Baradaran-Dilmaghani R., and Stanek G. In vitro susceptibility of thirty Borrelia strains from various sources against eight antimicrobial chemotherapeutics. Infection 24 (1996) 62-65
24. Alder J., Mitten M., Jarvis K., Gupta P., and Clement J. Efficacy of Clarithromycin for treatment of experimental Lyme disease in vivo. Antimicrob. Agents Chemother. 37 (1993) 1329-1333
25. Dever L.L., Jorgensen J.H., and Barbour A.G. Comparative in vitro activities of clarithromycin, Azithromycin and Erythromycin against Borrelia burgdorferi. Antimicrob. Agents Chemother. 37 (1993) 1704-1706
26. Mursic V.P., Wilske B., Schierz G., Holmburger M., and Suss E. In vitro and in vivo susceptibility of Borrelia burgdorferi. Eur. J. Clin. Microbiol. 6 (1987) 424-427
27. Johnson R.C., Kodner C., and Russel M. In vitro and in vivo susceptibility of the Lyme disease spirochete, Borrelia burgdorferi, to four antimicrobial agents. Antimicrob. Agents Chemother. 31 (1987) 164-167
28. Johnson R.C., Kodner C.B., and Jurkovich P.J. Comparative in vitro and in vivo susceptibilities of the Lyme disease spirochete Borrelia burgdorferi to Cefuroxime and other antimicrobial agents. Antimicrob. Agents Chemother. 34 (1990) 2133-2136
29. Cryan B., and Wright D.J.M. Antimicrobial agents in Lyme disease. J. Antimicrob. Chemother. 25 (1990) 187-190
30. Preac-Mursic V., Wilske B., Scheirz G., Suss E., and GroB B. Comparative antimicrobial activity of the new macrolides against Borrelia burgdorferi. Eur. J. Clin. Microbiol. Infect. Dis. 8 (1989) 651-653
31. Johnson R.C. Isolation techniques for spirochetes and their sensitivity to antibiotics in vitro and in vivo. Rev. Infect. Dis. 11 Suppl. 6 (1989) S1505-S1510
32. Nadelman R.B., and Wordmser G.P. Lyme borreliosis. Lancet 352 (1998) 557-565
33. Dever L.L., Jorgensen J.H., and Barbour A.G. In vitro antimicrobial susceptibility testing of Borrelia burgdorferi: a microdilution MIC method and time-kill studies. J. Clin. Microbiol. 30 (1992) 2692-2697
34. Eckman M.H., Steer A.C., Kalish R.A., and Pauker S.G. Cost effectiveness of oral as compared with intravenous antibiotic therapy for patients with early Lyme disease of Lyme arthritis. N. Engl. J. Med. 337 (1997) 357-363
35. Dattwyler R.J., Luft B.J., Kunkel M.J., Finkel M.F., Worsmser G.P., Rush T.J., et al. Ceftriaxone compared with doxycycline for the treatment of acute disseminated Lyme disease. N. Engl. J. Med. 337 (1997) 289-294
36. Dattwyler R.J., Volkman D.J., Conaty S.M., Plotkin S.P., and Luft B.J. Amoxycillin plus probenicid versus doxycycline for treatment of erythema migrans borreliosis. Lancet 336 (1990) 1404-1406
37. Muellegger R.R., Zoechling N., Schluepen E.M., Soyer H.P., Hoedl S., Kerl H., et al. Polymerase chain reaction control of antibiotic treatment in dermatoborreliosis. Infection 24 (1996) 78-81
38. Nadelman R.B., Luger S.W., Wisniewski M., Collins J., and Wormser G.P. Comparison of cefuroxime axetil and doxycycline in the treatment of early Lyme disease. Ann. Intern. Med. 117 (1992) 273-280
39. Breier F., Kunz G., Klade H., Stanek G., and Aberer E. Erythema migrans: three weeks treatment for prevention of Late Lyme borreliosis. Infection 24 (1996) 69-72
40. Steere A.C. Lyme disease. N. Engl. J. Med. 345 (2001) 115-125
41. Dattwyler R.J., Grunwaldt E., and Luft B. Clarithromycin in treatment of early Lyme disease: a pilot study. Antimicrob. Agents Chemother. 40 (1996) 468-469
42. Luft B.J., Dattwuler R.J., Johnson R.C., Luger S.W., Bosler E.M., Rahn D.W., et al. Azithromycin compared with amoxicillin in the treatment of Erythema migrans. Ann. Intern. Med. 124 (1996) 785-791
43. Massarotti E.M., Rahn D.W., Messner R.P., Wong J.B., Johnson R.C., and Steere A.C. Treatment of early Lyme disease. Am. J. Med. 92 (1992) 396-403
44. Strle F., Maraspin V., Lotric-Furlan S., Ruzic-Sabljic E., and Cimperman J. Azithromycin and doxycycline for treatment of Borrelia culture-positive Erythema migrans. Infection 24 (1996) 66-69
45. Strle F., Ruzic E., and Cimperman J. Erythema migrans: comparison of treatment with azithromycin, doxycycline and phenoxymethylpenicillin. J. Antimicrob. Chemother. 30 (1992) 543-550
46. Weber K., Wilske B., Preac-Mursic V., and Thurmayr R. Azithromycin versus Penicillin V for the treatment of early Lyme borreliosis. Infection 21 (1993) 19-24
47. Kahl O., Janetski-Mittmann C., Gray J.S., Jonas R., Stein J., and De Boer R. Risk of infection with Borrelia burgdorferi sensus lato for a host in relation to the duration of nymphal Ixodes ricinus feeding and the method of tick removal. Zentralbl. Bakteriol. 287 (1998) 41-52
48. Campbell G.L., Fritz C.L., Dish D., Nowakowski J., Nadelman R.B., and Wormser G.P. Estimation of the incidence of Lyme disease. Am. J. Epidemiol. 148 (1998) 1018-1026
49. Nahimana I., Gern L., Blanc D.S., Praz G., Francioli P., and Peter O. Risk of Borrelia burgdorferi infection in western Switzerland following a tick bite. Eur. J. Clin. Microbiol. Infect. Dis. 23 (2004) 603-608
50. Ferquel E., Garnier M., Marie J., Bernede-Baudin C., Baranton G., Perez-eid C., et al. Prevalence of Borrelia burgdorferi sensus lato and Anaplasmataceae members in Ixodes ricinus ticks in Alsace, a focus of Lyme borreliosis endemicity in France. Appl. Environ. Microbiol. 72 (2006) 3074-3078
51. Centre national de référence des Borrelia : rapport annuel d'activité 2003.
52. Centre national de référence des Borrelia : rapport annuel d'activité 2004.
53. Centre national de référence des Borrelia : rapport annuel d'activité 2005.
54. Quessada T., Martial-Convert F., Arnaud S., Leudet de la Vallee H., Gilot B., and Pichot J. Prevalence of Borrelia burgdorferi species in identification of Borrelia valaisiana in question Ixodes ricinus in the Lyon region of France as determined by polymerase chain reaction-restriction fragment length polymorphism. Eur. J. Clin. Microbiol. Infect. Dis. 22 (2003) 165-173
55. Ryffel K., Peter O., Rutti B., Suard A., and Dayer E. Scored antibody reactivity determined by immunoblotting shows an association between clinical manifestations and presence of Borrelia burgdorferi sensu stricto, Borrelia garinii, Borrelia afzelii, and Borrelia valaisiana in humans. J. Clin. Microbiol. 37 (1999) 4086-4092
56. Jouda F., Perret J.L., and Gern L. Density of questing Ixodes ricinus nymphs and adults infected by Borrelia burgdorferi sensus lato in Switzerland: spatio-temporal pattern at a regional scales. Vector Borne Zoonotic Dis. 1 (2004) 23-32
57. Benach J.L., Coleman J.L., Skinner R.A., and Bosier E.M. Adult Ixodes dammini on rabbits: a hypothesis for the development and transmission of Borrelia burgdorferi. J. Infect. Dis. 155 (1987) 1300
58. Piesman J., Dolan M.C., Schriefer M.E., and Burkot T.R. Ability of experimentally infected chickens to infect ticks with the Lyme disease spirochete, Borrelia burgdorferi. Am. J. Trop. Med. Hyg. 54 (1996) 294-298
59. Mataschka F.R., and Speilman A. Risk of infection from and treatment of tick bite. Lancet 342 (1993) 529-530
60. Piesman J., Maupin G.O., Campos E.G., and Happ C.M. Duration of adult female Ixodes dammini attachment and transmission of Borrelia burgdorferi, with description of a needle aspiration isolation method. J. Infect. Dis. 163 (1991) 895-896
61. Sood S.K., Salsman M.B., Johnson B.J.B., Happ C.M., Feig K., Carmody L., et al. Duration of tick attachment as a predictor of the risk of Lyme disease in an area in which Lyme disease is endemic. J. Infect. Dis. 175 (1997) 996-999
62. Des Vignes F., Piesman J., Heffernan R., Schulze T.L., Stafford K.C., and Fish D. Effect of tick removal on transmission of Borrelia burgdorferi and Ehrlichia phagocytophila by Ixodes scapularis nymphus. J. Infect. Dis. 183 (2001) 773-778
63. Piesman J., Mather T.N., Sinsky R.J., and Spielman A. Duration of tck attachment and Borrelia burgdorferi transmission. J. Clin. Microbiol. 25 (1987) 557-558
64. Falco R.C., Fish D., and Piesman J. Duration of tick bites in a Lyme disease-endemic area. Am. J. Epidemiol. 143 (1996) 187-192
65. Piesman J. Dynamics of Borrelia burgdorferi transmission by numphal Ixodes dammini ticks. J. Infect. Dis. 167 (1993) 1082-1085
66. Staneck G., and Kahl O. Chemoprophylaxis for Lyme borreliosis. Zentralbl. Bakteriol. 289 (1999) 655-665
67. Crippa M., Rais O., and Gern L. Investigations on the mode and dynamics of transmission and infectivity of Borrelia burgdorferi sensu stricto and Borrelia afzelii in Ixodes ricinus ticks. Vector Borne Zoonotic Dis. 1 (2002) 3-9
68. Peavey C.A., and Lane R.S. Comparison of infectivities of six tick-derived isolates of Borrelia burgdorferi for rodents and ticks. J. Clin. Microbiol. 34 (1996) 71-75
69. Paul H., Gerth H.J., and Ackermann R. Infectiousness for humans of Ixodes ricinus containing Borrelia burgdorferi. Zentralbl. Bakteriol. Mikrobiol. Hyg. 263 (1986) 473-476
70. McKiernan F.E., and Melsi J.W. Letter. N. Engl. J. Med. 328 (1993) 137-138
71. Maiwald M., Oehme R., March O., Petney T.N., Kimmig P., Naser K., et al. Transmission risk of Borrelia burgdorferi sensus lato from Ixodes ricinus ticks to humans in southwest Germany. Epidemiol. Infect. 121 (1998) 103-108
72. Korenberg E.I., Vorobyeva N.N., Moskvitina H.G., and Gorban L.Y. Prevention of borreliosis in persons bitten infected ticks. Infection 24 (1996) 187-189
73. Current trends update: Lyme disease and cases occurring during pregnancy - United states. MMWR 34 (1985) 376-378 (383-4)
74. Gardner T. Lyme disease. In: Remington J.S., and Klein J.O. (Eds). Infectious diseases of the fetus and newborn infant (1995), WB Saunders, Philadelphia 447-528
75. Markowitz L.E., Steere A.C., Benach J.L., Stade J.D., and Broome C.V. Lyme disease during pregnancy. JAMA 255 (1986) 3394-3396
76. Schlesinger P.A., Duray P.H., Burke B.A., Steere A.C., and Stillman M.T. Maternal-fetal transmission of the Lyme disease spirochete, Borrelia burgdorferi. Ann. Intern. Med. 103 (1985) 67-69
77. Sylver H.M. Lyme disease during pregnancy. Infect. Dis. Clin. North Am. 11 (1997) 93-97
78. Mather T.N., Telford S.R., and Adler G.H. Absence of transplacental transmission of Lyme disease spirochetes from reservoir mice (peromyscus leucopus) to their offspring. J. Infect. Dis. 164 (1991) 564-567
79. Strobino B.A., Williams C.L., Abid S., Chalson R., and Spierling P. Lyme disease and pregnancy outcome: a prospective study of two thousand prenatal patients. Am. J. Obstet. Gynecol. 169 (1993) 367-374
80. Maraspin V., Cimpeman J., Lotric-Furlan S., Pleterski-rigler D., and Strle F. Treatment of Erythema migrans in pregnancy. Clin. Infect. Dis. 22 (1996) 788-793
81. Williams C.L., Strobinot B., Weinstein A., Spierling P., and Medici F. Maternal Lyme disease and congenital malformations: a cord blood serosuvey in endemic and control areas. Paediatr. Perinat. Epidemiol. 9 (1995) 320-330
82. Strobino B., Abid S., and Gewitz M. Maternal Lyme disease and congenital heart disease: a case-control study in an endemic area. Am. J. Obstet. Gynecol. 180 (1999) 711-716
83. Maraspin V., Cimperman J., Lotric-Furlan S., Pleterski-Rigler D., and Strle F. Erythema migrans in pregnancy. Wein Klin Wochenschr. 111 (1999) 933-940
84. Nadelman R.B., Nowakowski J., Fish D., Falco R.C., Freeman K., McKenna D., et al. Prophylaxis with single-dose doxycycline for the prevention of Lyme disease after an Ixodes scapularis tick bite. N. Engl. J. Med. 345 (2001) 79-84
85. Shapiro E.D. Doxycycline for tick bites - not for everyone. N. Engl. J. Med. 345 (2001) 133
86. Feder H.M., Gerber M.A., Krause P.J., Ryan R., and Shapiro E. Early Lyme disease: a flu-like illness without Erythema migrans. Pediatrics 91 (1993) 456-459
87. Steere A.C., Dhar A., Hernandez J., Fischer P.A., Sikand V.K., Schoen R.T., et al. Systemic symptoms without Erythema migrans as the presenting picture of early Lyme disease. Am. J. Med. 114 (2003) 58-62
88. Leenders A.C.A.P. Single-dose doxycycline for the prevention of Lyme disease. N. Engl. J. Med. 345 (2001) 1349 (letter)
89. Weber K., and Pfister H.W. Clinical management of Lyme borreliosis. Lancet 343 (1994) 1017-1020
90. Fahrer H., Van Der Linden S.M., Sauvain M.J., Gern L., Zhioua E., and Aeschlimann A. The prevalence and incidence of clinical and asymptomatic Lyme/borreliosis in a population at risk. J. Infect. Dis. 163 (1991) 305-310
91. Steere A.C., Sikand V.K., Schoen R.T., and Nowakowsli J. Asymptomatic infection with Borrelia Burgdorferi. Clin. Infect. Dis. 37 (2003) 528-532
92. Steere A.C., Taylor E., Wilson M.L., Levine J.F., and Spielman A. Longitudinal assessment of the clinical and epidemiological features of Lyme disease in a defined population. J. Infect. Dis. 154 (1986) 295-300
93. Aguero-Rosenfeld M.A., Nowekowski J., Bittker S., Cooper D., Nadelman R.B., and Wormser G.P. Evolution of the serologic response to Borrelia burgdorferi in treated patients with culture-confirmed Erythema migrans. J. Clin. Microbiol. 34 (1996) 1-9
94. Zeidner N.S., Brandt K.S., Dadey E., Dolan M.C., Happ C., and Piesman J. Sustained-release formulation of doxycycline hycalte for prophylaxis of tick bite infection in amurine model of Lyme borreliosis. Antimicrob Agents Chemothers 48 (2004) 2697-2699
95. Nadelman R.B., and Wormser G.P. Single-dose doxycycline for the prevention of Lyme disease. N. Engl. J. Med. 345 (2001) 1349 (letter)
96. Wormser G.P. Controversies in the use of antimicrobial for the prevention and treatment of Lyme disease. Infection 24 (1996) 178-181
97. Magid D., Schwartz B., Craft J., and Schwartz J.S. Prevention of Lyme disease after tick bites. N. Engl. J. Med. 327 (1992) 534-541
98. Dennis D.T., and Meltzer M.I. Antibiotic prophylaxis after tick bites. Lancet 350 (1997) 1191-1192
99. Warshafsky S., Nowakowki J., Nadelman R.B., Kamer R.S., Peterson S.J., and Wormser G.P. Efficacy of antibiotic prophylaxis for prevention of Lyme disease. J. Gen. Intern. Med. 11 (1996) 329-333
100. Shapiro E.D., Gerber M.A., Holabird N.B., Berg A.T., Feder H.M., Bell G.L., et al. A controlled trial of antimicrobial prophylaxis for Lyme disease after deer-tick bites. N. Engl. J. Med. 327 (1992) 1769-1773
101. Agre F., and Schwartz R. The value of early treatment of deer tick bites for the prevention of Lyme disease. Am. J. Dis. Child. 147 (1993) 945-947
102. Costello C.M., Steere A.C., Pinkerton R.E., and Feder H.M. A prospective study of tick bites in an endemic area for Lyme disease. J. Infect. Dis. 159 (1989) 136-138
103. Shih C.M. Spielman. Topical prophylaxis for Lyme disease after tick bite in a roden Model. J. Infect. Dis. 168 (1993) 1043-1044
104. Hayes E.B., and Piesman J. How can we prevent Lyme disease?. N. Engl. J. Med. 348 (2003) 2424-2430
105. Sood S.K. Lyme disease. Pediatr. Infect. Dis. J. 18 (1999) 913-925